News Express: SKL-QRCM’s Academic Committee holds meeting at UM, acknowledging laboratory’s achievements
新聞快訊：中藥質量研究國家重點實驗室學術委員會會議澳大舉行 成果獲高度評價
中藥質量研究國家重點實驗室學術委員會會議於澳大舉行
The Academic Committee of SKL-QRCM holds its meeting at UM
中藥質量研究國家重點實驗室學術委員會會議澳大舉行
成果獲高度評價
中藥質量研究國家重點實驗室第二屆學術委員會第八次會議於澳門大學線上線下召開。學術委員會對國家重點實驗室取得的成果給予高度評價，尤其是對兩校國家重點實驗室的科技合作表示讚許。
澳門科學技術發展基金委員葉桂林，澳門科技大學校長李行偉，澳門大學副校長葛偉，國家重點實驗室學術委員會主任陳凱先院士和丁健院士，委員張伯禮院士、楊寶峰院士、王廣基院士、陳士林院士等多名專家學者以及國家重點實驗室主要學術人員通過線上或線下參會。葉桂林、李行偉和葛偉分別代表澳門科學技術發展基金和兩間大學致歡迎辭。其後陳凱先、丁健致辭，並對國家重點實驗室2023年度的建設和發展給予肯定。
中藥質量研究國家重點實驗室（澳大）主任陳新特聘教授代表兩校國家重點實驗室進行了2023年建設進展的匯報。他表示，2023年國家重點實驗室持續以中藥科技創新和澳門中藥産業發展需求為導向，在中藥質量評價的新技術和新方法、新發病機制與中藥新靶點、中藥新型遞送系統、中藥安全性評價、創新藥物研發與轉化研究等方面均取得了多項重要進展。國家重點實驗室發表SCI期刊論文766篇，獲授權專利21項。依託國家重點實驗室建設的“澳門中藥研發中心”順利通過第一階段建設評估，澳大澳門中藥檢測中心亦通過中國合格評定國家認可委員會（CNAS）的現場評審並獲認證。同時，國家重點實驗室舉辦多場國際學術會議，SCI期刊Chinese Medicine的影響力亦逐年提升，積極推動國際交流與合作。
學術委員會對國家重點實驗室取得的成果給予高度評價，尤其是對兩校國家重點實驗室的科技合作表示讚許。委員們對國家重點實驗室未來的建設和發展提出了多項建議，包括進一步明晰定位並凸顯研究特色、凝練中藥質量內涵並建立中藥質量的指標體系和評價體系、注重新技術與新方法的開發與應用、加強中藥國際標準制定、善用澳門中藥獨立審評體系以推動海內外藥品註冊等。
陳新和中藥質量研究國家重點實驗室（澳門科技大學）主任姜志宏講座教授代表兩個依託機構，感謝委員們對國家重點實驗室工作成績的肯定，並表示將根據委員們所提出的建議，對國家重點實驗室的發展作進一步優化，將國家重點實驗室建設成為中藥質量科技創新與國際合作基地。
欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/press-release/detail/57569/
SKL-QRCM’s Academic Committee holds meeting at UM, acknowledging laboratory’s achievements
The Second Academic Committee of the State Key Laboratory of Quality Research in Chinese Medicine (SKL-QRCM) held its eighth meeting at the University of Macau (UM). The meeting, held in a hybrid format, was attended by Ip Kuai Lam, member of the Administrative Committee of the Science and Technology Development Fund of Macao; Lee Hun Wei, president of the Macau University of Science and Technology (MUST); Ge Wei, vice rector of UM; Chen Kaixian and Ding Jian, directors of the Academic Committee; as well as other committee members and laboratory members.
During the meeting, Ip, Lee, and Ge delivered welcoming speeches, followed by speeches by Chen and Ding. Chen Xin, Distinguished Professor at UM and director of SKL-QRCM (UM), presented to the committee the progress of SKL-QRCM in 2023 on behalf of both SKL-QRCM (UM) and SKL-QRCM (MUST). According to Chen, SKL-QRCM, by focusing on technological innovation and the development needs of the Chinese medicine industry in Macao, made significant achievements in various areas in 2023, including Chinese medicine quality assessment, identification of new pathogenesis and targets, international collaborations, publications, and patents. In addition, with the support of SKL-QRCM, the first phase of assessment for the construction of Macao Centre for Research and Development in Chinese Medicine was successfully completed, and Macao Centre for Testing of Chinese Medicine obtained accreditation from China National Accreditation Service for Conformity Assessment. The Academic Committee acknowledged the achievements SKL-QRCM made in 2023, particularly its progress in technological collaborations between UM and MUST. Moreover, members of the committee provided valuable suggestions for the future development of SKL-QRCM.
To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/57569/